Advertisement

Journal of Cancer Survivorship

, Volume 1, Issue 4, pp 283–291 | Cite as

Pilot study of acupuncture for the treatment of joint symptoms related to adjuvant aromatase inhibitor therapy in postmenopausal breast cancer patients

  • Katherine D. Crew
  • Jillian L. Capodice
  • Heather Greenlee
  • Arlyn Apollo
  • Judith S. Jacobson
  • George Raptis
  • Kimberly Blozie
  • Alex Sierra
  • Dawn L. HershmanEmail author
Article

Abstract

Introduction

Aromatase inhibitors (AIs) have become the standard of care for the adjuvant treatment of postmenopausal, hormone-sensitive breast cancer. However, patients receiving AIs may experience joint symptoms, which may lead to early discontinuation of this effective therapy. We hypothesize that acupuncture is a safe and effective treatment for AI-induced arthralgias.

Methods

Postmenopausal women with early-stage breast cancer who had self-reported musculoskeletal pain related to adjuvant AI therapy were randomized in a crossover study to receive acupuncture twice weekly for 6 weeks followed by observation or vice-versa. The intervention included full body and auricular acupuncture, and a joint-specific point prescription. Outcome measures included the Brief Pain Inventory-Short Form (BPI-SF), Western Ontario and McMaster Universities Osteoarthritis (WOMAC) index, the Functional Assessment of Cancer Therapy-General (FACT-G) quality of life measure, and serum levels of inflammatory markers, IL-1β and TNF-α.

Results

Twenty-one women were enrolled and two discontinued early. From baseline to the end of treatment, patients reported improvement in the mean BPI-SF worst pain scores (5.3 to 3.3, p = 0.01), pain severity (3.7 to 2.5, p = 0.02), and pain-related functional interference (3.1 to 1.7, p = 0.02), as well as the WOMAC function subscale and FACT-G physical well-being (p = 0.02 and 0.04, respectively). No adverse events were reported.

Discussion/conclusions

In this pilot study, acupuncture reduced AI-related joint symptoms and improved functional ability and was well-tolerated.

Implications for cancer survivors

Musculoskeletal side effects are common among breast cancer survivors on adjuvant AI therapy, therefore, effective treatments are needed for symptom relief and to improve adherence to these life-saving medications.

Keywords

Acupuncture Aromatase inhibitor Breast cancer Joint pain/stiffness 

References

  1. 1.
    Baum M, Budzar AU, Cuzick J, Forbes J, Houghton JH, Klijn JG, et al. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial. Lancet. 2002;359:2131–39.PubMedCrossRefGoogle Scholar
  2. 2.
    Goss PE, Ingle JN, Martino S, Robert NJ, Muss HB, Piccart MJ, et al. A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer. N Engl J Med. 2003;349:1793–1802.PubMedCrossRefGoogle Scholar
  3. 3.
    Baum M, Buzdar A, Cuzick J, Forbes J, Houghton J, Howell A, et al. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses. Cancer. 2003;98:1802–1810.PubMedCrossRefGoogle Scholar
  4. 4.
    Coombes RC, Hall E, Gibson LJ, Paridaens R, Jassem J, Delozier T, et al. A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. N Engl J Med. 2004;350:1081–1092.PubMedCrossRefGoogle Scholar
  5. 5.
    Crew KD, Greenlee H, Capodice J, Raptis G, Brafman L, Fuentes D, Sierra A, Hershman DL. Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer. J Clin Oncol. 2007;25:3877–3883.PubMedCrossRefGoogle Scholar
  6. 6.
    Donnellan PP, Douglas SL, Cameron DA, Leonard RC. Aromatase inhibitors and arthralgia. J Clin Oncol. 2001;19:15.Google Scholar
  7. 7.
    Riggs BL, Melton LJ, 3rd. The prevention and treatment of osteoporosis. N Engl J Med. 1992;327:620–627.PubMedCrossRefGoogle Scholar
  8. 8.
    Sherwin BB. Hormones, mood, and cognitive functioning in postmenopausal women. Obstet Gynecol. 1996;87.Google Scholar
  9. 9.
    Kramer PR, Kramer SF, Guan G. 17 beta-estradiol regulates cytokine release through modulation of CD16 expression in monocytes and monocyte-derived macrophages. Arthritis Rheum. 2004;50:1967–1975.PubMedCrossRefGoogle Scholar
  10. 10.
    Andersson S, Lundeberg T. Acupuncture—from empiricism to science: functional background to acupuncture effects in pain and disease. Med Hypotheses. 1995;45:271–281.PubMedCrossRefGoogle Scholar
  11. 11.
    Han JS, Terenius L. Neurochemical basis of acupuncture analgesia. Annu Rev Pharmacol Toxicol. 1982;22:193–220.PubMedCrossRefGoogle Scholar
  12. 12.
    Takeda W, Wessel J. Acupuncture for the treatment of pain of osteoarthritic knees. Arthritis Care Res. 1994;7:118–122.PubMedCrossRefGoogle Scholar
  13. 13.
    Christensen BV, Iuhl IU, Vilbek H, Bulow HH, Dreijer NC, Rasmussen HF. Acupuncture treatment of severe knee osteoarthrosis. a long-term study. Acta Anaesthesiol Scand. 1992;36:519–525.PubMedGoogle Scholar
  14. 14.
    Ezzo J, Hadhazy V, Birch S, Lao L, Kaplan G, Hochberg M, Berman B. Acupuncture for osteoarthritis of the knee: a systematic review. Arthritis Rheum. 2001;44:819–825.PubMedCrossRefGoogle Scholar
  15. 15.
    Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singap. 1994;23:129–138.PubMedGoogle Scholar
  16. 16.
    Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988;15:1833–1840.PubMedGoogle Scholar
  17. 17.
    Brady MJ, Cella DF, Mo F, Bonomi AE, Tulsky DS, Lloyd SR, et al. Reliability and validity of the functional assessment of cancer therapy—breast quality-of-life instrument. J Clin Oncol. 1997;15:974–986.PubMedGoogle Scholar
  18. 18.
    MacPherson H, White A, Cummings M, Jobst KA, Rose K, Niemtzow RC. Standards for reporting interventions in controlled trials of acupuncture: the STRICTA recommendations. J Altern Complement Med. 2002;8:85–89.PubMedCrossRefGoogle Scholar
  19. 19.
    Xinnong C. Chinese Acupuncture and Moxibustion. In: Foreign Languages Press, Beijing, 1999:134–226.Google Scholar
  20. 20.
    Shanghai College of Traditional Medicine. Acupuncture, A Comprehensive Text. Eastland Press, Seattle, 1981.Google Scholar
  21. 21.
    Usichenko TI, Kuchling S, Witstruck T, Pavlovic D, Zach M, Hofer A, et al. Auricular acupuncture for pain relief after ambulatory knee surgery: a randomized trial. Cmaj. 2007;176:179–183.PubMedGoogle Scholar
  22. 22.
    Castel LD, Abernethy AP, Li Y, Depuy V, Saville BR, Hartmann KE. Hazards for pain severity and pain interference with daily living, with exploration of brief pain inventory cutpoints, among women with metastatic breast cancer. J Pain Symptom Manage, 2007.Google Scholar
  23. 23.
    Jensen MP, Turner JA, Romano JM, Fisher LD. Comparative reliability and validity of chronic pain intensity measures. Pain. 1999;83:157–162.PubMedCrossRefGoogle Scholar
  24. 24.
    Cancer Therapy Evaluation Program, Common Terminology Criteria for Adverse Events, Version 3.0, DCTD, NCI, NIH, DHHS, March 31, 2003 (http://ctep.cancer.gov).
  25. 25.
    Bonneterre J, Thurlimann B, Robertson JF, Krzakowski M, Mauriac L, Koralewski P, et al. Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women: results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability study.[see comment]. J Clin Oncol. 2000;18:3748–3757.PubMedGoogle Scholar
  26. 26.
    McGuire WP, Hoskins WJ, Brady MF, Kucera PR, Partridge EE, Look KY, et al. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Eng J Med. 1996;334:1–6.CrossRefGoogle Scholar
  27. 27.
    Cecil RL, Archer BH. Arthritis of the menopause. JAMA. 1925;84:75–79.Google Scholar
  28. 28.
    Nevitt MC, Cummings SR, Lane NE, Hochberg MC, Scott JC, Pressman AR, et al. Association of estrogen replacement therapy with the risk of osteoarthritis of the hip in elderly white women. Study of Osteoporotic Fractures Research Group. Arch Intern Med. 1996;156:2073–2080.PubMedCrossRefGoogle Scholar
  29. 29.
    Hannan MT, Felson DT, Anderson JJ, Naimark A, Kannel WB. Estrogen use and radiographic osteoarthritis of the knee in women. The Framingham Osteoarthritis Study. Arthritis Rheum. 1990;33:525–532.PubMedCrossRefGoogle Scholar
  30. 30.
    Spector TD, Nandra D, Hart DJ, Doyle DV. Is hormone replacement therapy protective for hand and knee osteoarthritis in women? The Chingford Study. Ann Rheum Dis. 1997;56:432–434.PubMedGoogle Scholar
  31. 31.
    Chlebowski RT, Johnson KC, Kooperberg C, Hubbell A, Lane D, O’Sullivan M, et al. The Women’s Health Initiative randomized trial of calcium plus vitamin D: effects on breast cancer and arthralgias. Am Soc Clin Oncol. 2006.Google Scholar
  32. 32.
    da Silva JA, Colville-Nash P, Spector TD, Scott DL, Willoughby DA. Inflammation-induced cartilage degradation in female rodents. Protective role of sex hormones. Arthritis Rheum. 1993;36:1007–1013.PubMedCrossRefGoogle Scholar
  33. 33.
    Saklatvala J. Tumour necrosis factor alpha stimulates resorption and inhibits synthesis of proteoglycan in cartilage. Nature. 1986;322:547–549.PubMedCrossRefGoogle Scholar
  34. 34.
    Henderson B, Pettipher ER. Arthritogenic actions of recombinant IL-1 and tumour necrosis factor alpha in the rabbit: evidence for synergistic interactions between cytokines in vivo. Clin Exp Immunol. 1989;75:306–310.PubMedGoogle Scholar
  35. 35.
    Wooley PH, Whalen JD, Chapman DL, Berger AE, Richard KA, Aspar DG, Staite ND. The effect of an interleukin-1 receptor antagonist protein on type II collagen-induced arthritis and antigen-induced arthritis in mice. Arthritis Rheum. 1993;36:1305–1314.PubMedCrossRefGoogle Scholar
  36. 36.
    Sjolund B, Terenius L, Eriksson M. Increased cerebrospinal fluid levels of endorphins after electro-acupuncture. Acta Physiol Scand. 1977;100:382–384.PubMedCrossRefGoogle Scholar
  37. 37.
    Pomeranz B, Chiu D. Naloxone blockade of acupuncture analgesia: endorphin implicated. Life Sci. 1976;19:1757–1762.PubMedCrossRefGoogle Scholar
  38. 38.
    Kawakita K. Polymodal receptor hypothesis on the peripheral mechanisms of acupuncture and moxibustion. Am J Acupunct. 1993;21:331–338.Google Scholar
  39. 39.
    Kawakita K, Shinbara H, Imai K, Fukuda F, Yano T, Kuriyama K. How do acupuncture and moxibustion act? Focusing on the progress in Japanese acupuncture research. J Pharmacol Sci. 2006;100:443–459.PubMedCrossRefGoogle Scholar
  40. 40.
    Matsumoto T, Takashima B. Influences of acupuncture to the neck and shoulder on the blood circulation of the upper limbs. J Japn Soc Acupunct Mox. 1981;30:209–216.Google Scholar
  41. 41.
    Shinohara S. The influence of acupuncture, low frequency electrical acupuncture and SSP stimulation on local blood circulation. J Jpn Soc Acupunct Mox. 1982;32:17–23.Google Scholar
  42. 42.
    Roscoe JA, Morrow GR, Hickok JT, Bushunow P, Pierce HI, Flynn PJ, et al. The efficacy of acupressure and acustimulation wrist bands for the relief of chemotherapy-induced nausea and vomiting. A University of Rochester Cancer Center Community Clinical Oncology Program Multicenter study. J Pain Symptom Manage. 2003;26:731–742.PubMedCrossRefGoogle Scholar
  43. 43.
    Johnstone PA, Niemtzow RC, Riffenburgh RH. Acupuncture for xerostomia: clinical update. Cancer. 2002;94:1151–1156.PubMedCrossRefGoogle Scholar
  44. 44.
    Johnstone PA, Peng YP, May BC, Inouye WS, Niemtzow RC. Acupuncture for pilocarpine-resistant xerostomia following radiotherapy for head and neck malignancies. Int J Radiat Oncol Biol Phys. 2001;50:353–357.PubMedCrossRefGoogle Scholar
  45. 45.
    Wong RK, Jones GW, Sagar SM, Babjak AF, Whelan T. A Phase I–II study in the use of acupuncture-like transcutaneous nerve stimulation in the treatment of radiation-induced xerostomia in head-and-neck cancer patients treated with radical radiotherapy. Int J Radiat Oncol Biol Phys. 2003;57:472–480.PubMedCrossRefGoogle Scholar
  46. 46.
    Chen C, Zhang Z, Li H, et al. Electroacupuncture on Zusangli (ST36) to reduce chemotherapy induced toxicity. Xin Zhong Yi. 2004;36:46–47.Google Scholar
  47. 47.
    Lu W. Acupuncture for side effects of chemoradiation therapy in cancer patients. Semin Oncol Nurs. 2005;21:190–195.PubMedCrossRefGoogle Scholar
  48. 48.
    Hui KK, Hui EK, Johnston MF. The potential of a person-centered approach in caring for patients with cancer: a perspective from the UCLA center for East–West medicine. Integr Cancer Ther. 2006;5:56–62.PubMedCrossRefGoogle Scholar
  49. 49.
    Alimi D, Rubino C, Pichard-Leandri E, Fermand-Brule S, Dubreuil-Lemaire ML, Hill C. Analgesic effect of auricular acupuncture for cancer pain: a randomized, blinded, controlled trial. J Clin Oncol. 2003;21:4120–4126.PubMedCrossRefGoogle Scholar
  50. 50.
    Lee H, Schmidt K, Ernst E. Acupuncture for the relief of cancer-related pain–a systematic review. Eur J Pain. 2005;9:437–444.PubMedCrossRefGoogle Scholar
  51. 51.
    Ernst E, Pittler MH, Wider B, Boddy K. Acupuncture: its evidence-base is changing. Am J Chin Med. 2007;35:21—25.PubMedCrossRefGoogle Scholar
  52. 52.
    Brinkhaus B, Becker-Witt C, Jena S, Linde K, Streng A, Wagenpfeil S, Irnich D, Hummelsberger J, Melchart D, Willich SN. Acupuncture Randomized Trials (ART) in patients with chronic low back pain and osteoarthritis of the knee—design and protocols. Forsch Komplementarmed Klass Naturheilkd. 2003;10:185–191.PubMedCrossRefGoogle Scholar
  53. 53.
    Vas J, Mendez C, Perea-Milla E, Vega E, Panadero M, Leon J, et al. Acupuncture as a complementary therapy to the pharmacological treatment of osteoarhritis of the knee: randomised controlled trial. Br Med J. 2004;DOI  10.1136, 1–5.
  54. 54.
    Ernst E, White AR. Prospective studies of the safety of acupuncture: a systematic review. Am J Med. 2001;110:481–485.PubMedCrossRefGoogle Scholar
  55. 55.
    Vincent C. The safety of acupuncture. Bmj. 2001;323:467–468.PubMedCrossRefGoogle Scholar
  56. 56.
    Gray RE, Fitch M, Goel V, Franssen E, Labrecque M. Utilization of complementary/alternative services by women with breast cancer. J Health Soc Policy. 2003;16:75–84.PubMedCrossRefGoogle Scholar
  57. 57.
    Lengacher CA, Bennett MP, Kip KE, Keller R, LaVance MS, Smith LS, Cox CE. Frequency of use of complementary and alternative medicine in women with breast cancer. Oncology Nursing Forum. Online. 2002;29:1445–1452.CrossRefGoogle Scholar
  58. 58.
    Navo MA, Phan J, Vaughan C, Palmer JL, Michaud L, Jones KL, et al. An assessment of the utilization of complementary and alternative medication in women with gynecologic or breast malignancies. J Clin Oncol. 2004;22:671–677.PubMedCrossRefGoogle Scholar
  59. 59.
    Gibson D, Bruton A, Lewith GT, Mullee M. Effects of acupuncture as a treatment for hyperventilation syndrome: a pilot, randomized crossover trial. J Altern Complement Med. 2007;13:39–46.PubMedCrossRefGoogle Scholar
  60. 60.
    Reindl TK, Geilen W, Hartmann R, Wiebelitz KR, Kan G, Wilhelm I, et al. Acupuncture against chemotherapy-induced nausea and vomiting in pediatric oncology. Interim results of a multicenter crossover study. Support Care Cancer. 2006;14:172–176.PubMedCrossRefGoogle Scholar
  61. 61.
    Karst M, Scheinichen D, Rueckert T, Wagner T, Wiese B, Fink M. Acupuncture has no immediate treatment effect on the neutrophil respiratory burst: a randomized single-blinded two-period crossover study. Brain Behav Immun. 2002;16:813–816.PubMedCrossRefGoogle Scholar
  62. 62.
    Scharf HP, Mansmann U, Streitberger K, Witte S, Kramer J, Maier C, et al. Acupuncture and knee osteoarthritis: a three-armed randomized trial. Ann Intern Med. 2006;145:12–20.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Katherine D. Crew
    • 1
    • 2
    • 3
  • Jillian L. Capodice
    • 2
  • Heather Greenlee
    • 3
  • Arlyn Apollo
    • 1
  • Judith S. Jacobson
    • 2
    • 3
  • George Raptis
    • 1
    • 2
  • Kimberly Blozie
    • 1
    • 2
  • Alex Sierra
    • 1
    • 2
  • Dawn L. Hershman
    • 1
    • 2
    • 3
    • 4
    Email author
  1. 1.Department of Medicine, College of Physicians and SurgeonsColumbia UniversityNew YorkUSA
  2. 2.Herbert Irving Comprehensive Cancer CenterColumbia UniversityNew YorkUSA
  3. 3.Department of Epidemiology, Mailman School of Public HealthColumbia UniversityNew YorkUSA
  4. 4.Columbia UniversityNew YorkUSA

Personalised recommendations